ADRENAL: Difference between revisions

Jump to navigation Jump to search
13 bytes added ,  30 January 2018
no edit summary
(Ready for editor review)
No edit summary
Line 1: Line 1:
{{info
{{info
| title=Adjunctive Glucocorticoid Therapy in Patients with Septic Shock
| title=Adjunctive glucocorticoid therapy in patients with septic shock
| abbreviation=ADRENAL
| abbreviation=ADRENAL
| expansion=
| expansion=
Line 47: Line 47:
** Hydrocortisone (n=1832)
** Hydrocortisone (n=1832)
** Placebo (n=1826)
** Placebo (n=1826)
* Setting: Australia (45 sites), UK (12), New Zealand (8),
* Setting: Australia (45 sites), UK (12), New Zealand (8), Saudi Arabia (3), and Denmark (1)
Saudi Arabia (3), and Denmark (1)
* Enrollment: March 2013 to April 2017
* Enrollment: March 2013 to April 2017
* Mean follow-up: 90 days
* Mean follow-up: 90 days
* Analysis: ITT
* Analysis: Intention-to-treat
* Primary Outcome: 90 day mortality
* Primary Outcome: 90 day mortality


Bureaucrats, editor, reviewer, Administrators
6,387

edits

Navigation menu